Walker Luke Nathaniel has filed 5 insider transactions across 2 companies since May 2024.
Most recent transaction: a grant/award of 57603 shares of Zentalis Pharmaceuticals, Inc. ($ZNTL) on June 17, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 17, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Walker Luke Nathaniel | Director | A | Common Stock | 57603 | $0.00 | 144,284.0000 | 71,811,508 | 66.45% | 0.08% |
| June 12, 2025 | Context Therapeutics Inc. | $CNTX | Walker Luke Nathaniel | Director | A | Stock Option (right to buy) | 123500 | $0.00 | 123,500.0000 | 58,416,141 | 9999.99% | 0.21% |
| Jan. 31, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Walker Luke Nathaniel | Director | P | Common Stock | 14200 | $1.76 | 86,681.0000 | 0 | 19.59% | 0.00% |
| Sept. 4, 2024 | Context Therapeutics Inc. | $CNTX | Walker Luke Nathaniel | Director | A | Stock Option (right to buy) | 19315 | $0.00 | 19,315.0000 | 15,966,053 | 9999.99% | 0.12% |
| May 24, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Walker Luke Nathaniel | Director | A | Common Stock | 72481 | $0.00 | 72,481.0000 | 0 | 9999.99% | 0.00% |